Gainers

• HCW Biologics (NASDAQ:HCWB) stock increased by 70.3% to $0.57 during Thursday's after-market session. The market value of their outstanding shares is at $2.3 million. As per the press release, Q1 earnings came out today.
• P3 Health Partners (NASDAQ:PIII) stock moved upwards by 47.14% to $5.93. The market value of their outstanding shares is at $11.7 million. The company's, Q1 earnings came out today.
• Alpha Cognition (NASDAQ:ACOG) stock rose 10.73% to $6.29. The company's market cap stands at $129.5 million. The company's, Q1 earnings came out today.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) stock moved upwards by 9.64% to $0.7. The market value of their outstanding shares is at $3.9 million.
• Voyager Therapeutics (NASDAQ:VYGR) shares increased by 7.25% to $4.55. The market value of their outstanding shares is at $250.7 million.
• AVITA Medical (NASDAQ:RCEL) stock increased by 7.11% to $4.67. The company's market cap stands at $131.1 million. As per the press release, Q1 earnings came out today.

Losers

• Dare Bioscience (NASDAQ:DARE) stock declined by 30.1% to $2.0 during Thursday's after-market session. The company's market cap stands at $41.3 million. As per the news, the Q1 earnings report came out today.
• Aardvark Therapeutics (NASDAQ:AARD) stock declined by 15.16% to $5.71. The company's market cap stands at $143.7 million.
• Wellgistics Health (NASDAQ:WGRX) stock decreased by 10.11% to $0.08. The company's market cap stands at $12.2 million.
• Zentek (NASDAQ:ZTEK) shares declined by 10.0% to $0.9. The market value of their outstanding shares is at $108.6 million.
• Co-Diagnostics (NASDAQ:CODX) shares decreased by 9.82% to $1.47. The company's market cap stands at $3.3 million. As per the news, the Q1 earnings report came out today.
• Akanda (NASDAQ:AKAN) stock decreased by 9.04% to $22.65. The market value of their outstanding shares is at $12.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.